INTRODUCTION: The aim was to analyse mortality and estimate the life expectancy among people hospitalised for alcohol use disorders (AUD) compared with the general Czech population aged ≥20 years. A temporal perspective on excess mortality was used, covering three recent calendar periods before and during the pandemic. METHODS: Three retrospective cohorts of the target population were constructed using registry-based data. The target population was defined as all adult patients (aged ≥20 years) admitted to the hospital for AUD (ICD-10 dg. of F10.x) between 2010 and 2021. Age-adjusted mortality rates and life expectancies were calculated for the comparative analysis. Official Czech mortality and vital statistics were used for the comparison. A Poisson log-linear regression model was used to test the effect of the pandemic period (2020-2021) on mortality in the AUD target population. RESULTS: At age 20, the estimated life expectancy of the AUD target was 21-27 years less than that of the Czech general population. Excess mortality was relatively highest in young people aged 20-34 years and in adults aged 35-49 years. During the pandemic period 2020-2021, mortality rates in the target AUD increased significantly. However, relative inequalities with the general Czech population did not change significantly. DISCUSSION AND CONCLUSIONS: People hospitalised for AUD have much higher mortality rates, resulting in markedly reduced life expectancy. During the pandemic, their mortality rates increased even more. However, the increase was no greater than in the general Czech population.

National Institute of Mental Health Klecany Czech Republic

Zobrazit více v PubMed

Carvalho AF, Heilig M, Perez A, Probst C, Rehm J. Alcohol use disorders. Lancet. 2019;394:781–792. PubMed

Rehm J, Shield KD. Alcohol and mortality: global alcohol‐attributable deaths from cancer, liver cirrhosis, and injury in 2010. Alcohol Res. 2013;35:174–183. PubMed PMC

Mravčík V, Chomynová P, Nechanská B, Černíková T, Csémy L. Alcohol use and its consequences in the Czech Republic. Cent Eur J Public Health. 2019;27:S15–S28. PubMed

Csémy, L , Dvořáková, Z , Fialová, A , Kodl, M , Malý, M , Skývová, M . Národní výzkum užívání tabáku a alkoholu v České republice 2021, NAUTA [National Survey on Tobacco and Alcohol Use in the Czech Republic 2021, NAUTA]. Praha: Státní zdravotní ústav [National Institute of Public Health]; 2022.

Nechanská B, Drbohlavová B, Csémy L. Struktura mortality osob ústavně léčených pro poruchy vyvolané alkoholem v ČR v letech 1994–2013 [Structure of mortality of persons hospitalised for alcohol use disorders in the Czech Republic from 1994 to 2013]. Adiktologie. 2017;17:84–91.

Formánek T, Krupchanka D, Mladá K, Winkler P, Jones PB. Mortality and life‐years lost following subsequent physical comorbidity in people with pre‐existing substance use disorders: a national registry‐based retrospective cohort study of hospitalised individuals in Czechia. Lancet Psychiatry. 2022;9:957–968. PubMed

Roberts A, Rogers J, Mason R, Siriwardena AN, Hogue T, Whitley GA, et al. Alcohol and other substance use during the COVID‐19 pandemic: a systematic review. Drug Alcohol Depend. 2021;229:109150. PubMed PMC

Rehm J, Kilian C, Ferreira‐Borges C, Jernigan D, Monteiro M, Parry CDH, et al. Alcohol use in times of the COVID 19: implications for monitoring and policy. Drug Alcohol Rev. 2020;39:301–304. PubMed PMC

Dubey S, Biswas P, Ghosh R, Chatterjee S, Dubey MJ, Chatterjee S, et al. Psychosocial impact of COVID‐19. Diabetes Metab Syndr. 2020;14:779–788. PubMed PMC

Institute of Health Information and Statistics . Psychiatrická ročenka 2021 [Psychiatric Yearbook 2021]. Praha: Ústav zdravotnických informací a statistiky ČR [Institute of Health Information and Statistics]; 2022.

Kilian C, Carr S, Schulte B, Manthey J. Increased alcohol‐specific mortality in Germany during COVID‐19: state‐level trends from 2010 to 2020. Drug Alcohol Rev. 2023;42:633–640. PubMed PMC

Office for National Statistics . Alcohol‐specific deaths in the UK: registered in 2021. Office of National Statistics; 2022. Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/alcoholspecificdeathsintheuk/2021registrations

White AM, Castle IP, Powell PA, Hingson RW, Koob GF. Alcohol‐related deaths during the COVID‐19 pandemic. JAMA. 2022;327:1704–1706. PubMed PMC

Bailey KL, Samuelson DR, Wyatt TA. Alcohol use disorder: a pre‐existing condition for COVID‐19? Alcohol. 2021;90:11–17. PubMed PMC

Deutsch‐Link S, Curtis B, Singal AK. Covid‐19 and alcohol associated liver disease. Dig Liver Dis. 2022;54:1459–1468. PubMed PMC

Huang BH, Inan‐Eroglu E, Shaban RZ, Hamer M, Britton A, Stamatakis E. Alcohol intake and mortality risk of COVID‐19, pneumonia, and other infectious diseases: an analysis of 437191 UK biobank participants. Prev Med Rep. 2022;26:101751. PubMed PMC

Eurostat . Revision of the European standard population: report of the Eurostat's task force. Luxembourg: Publications Office of the European Union; 2013.

Breslow NE, Day NE. Statistical methods in cancer research. II – the design and analysis of cohort studies. Lyon: International Agency for Research on Cancer; 1987. PubMed

Roerecke M, Rehm J. Alcohol use disorders and mortality: a systematic review and meta‐analysis. Addiction. 2013;108:1562–1578. PubMed

Hayes RD, Chang CK, Fernandes A, Broadbent M, Lee W, Hotopf M, et al. Associations between substance use disorder sub‐groups, life expectancy and all‐cause mortality in a large British specialist mental healthcare service. Drug Alcohol Depend. 2011;118:56–61. PubMed

Westman J, Wahlbeck K, Laursen TM, Gissler M, Nordentoft M, Hällgren J, et al. Mortality and life expectancy of people with alcohol use disorder in Denmark, Finland and Sweden. Acta Psychiatr Scand. 2015;131:297–306. PubMed PMC

John U, Rumpf HJ, Bischof G, Hapke U, Hanke M, Meyer C. Excess mortality of alcohol‐dependent individuals after 14 years and mortality predictors based on treatment participation and severity of alcohol dependence. Alcohol Clin Exp Res. 2013;37:156–163. PubMed

Garnett C, Jackson S, Oldham M, Brown J, Steptoe A, Fancourt D. Factors associated with drinking behaviour during COVID‐19 social distancing and lockdown among adults in the UK. Drug Alcohol Depend. 2021;219:108461. PubMed PMC

Chodkiewicz J, Talarowska M, Miniszewska J, Nawrocka N, Bilinski P. Alcohol consumption reported during the COVID‐19 pandemic: the initial stage. Int J Environ Res Public Health. 2020;17:4677. PubMed PMC

Koopmann A, Georgiadou E, Kiefer F, Hillemacher T. Did the general population in Germany drink more alcohol during the COVID‐19 pandemic lockdown? Alcohol Alcohol. 2020;55:698–699. PubMed PMC

Torales J, O'Higgins M, Castaldelli‐Maia JM, Ventriglio A. The outbreak of COVID‐19 coronavirus and its impact on global mental health. Int J Soc Psychiatry. 2020;66:317–320. PubMed

Yazdi K, Fuchs‐Leitner I, Rosenleitner J, Gerstgrasser NW. Impact of the COVID‐19 pandemic on patients with alcohol use disorder and associated risk factors for relapse. Front Psychiatry. 2020;11:620612. PubMed PMC

Murthy P, Narasimha VL. Effects of the COVID‐19 pandemic and lockdown on alcohol use disorders and complications. Curr Opin Psychiatry. 2021;34:376–385. PubMed PMC

Mravčík V, Chomynová P. Substance use and addictive behaviours during COVID‐19 confinement measures increased in intensive users: results of an online general population survey in the Czech Republic. Epidemiol Mikrobiol Immunol. 2021;70:98–103. PubMed

Chomynová P, Grohmannová K, Dvořáková Z, Orlíková B, Rous Z, Černíková T. Souhrnná zpráva o závislostech v České republice 2022 [Summary report on addictions in the Czech Republic in 2022]. Praha: Úřad vlády České republiky [Office of The Government of the Czech Republic]; 2023.

Orlíková B, Soběhart R, Fanta M, Dvořáková Z, Rod A. Efektivita systému adiktologických služeb v České republice v souvislosti s pandemií COVID‐19. Souhrnná zpráva o výzkumu [Effectiveness of the addiction services system in the Czech Republic in connection with the COVID‐19 pandemic. Research summary report]. Klecany: Národní ústav duševního zdraví [National Institute of Mental Health]; 2022.